Kepler Capital analyst David Evans maintained a Hold rating on Galapagos (NASDAQ:GLPG) on Tuesday, setting a price target of EUR79, which is approximately 27.98% above the present share price of $75.14.
Evans expects Galapagos to post earnings per share (EPS) of $0.14 for the second quarter of 2021.
The current consensus among 9 TipRanks analysts is for a Moderate Buy rating of shares in Galapagos, with an average price target of $102.14.
The analysts price targets range from a high of $133.9 to a low of $87.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $113.89 million and a net profit of -$50.8 million. The company's market cap is $4.92 billion.
According to TipRanks.com, Kepler Capital analyst David Evans is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 8.7% and a 67.35% success rate.
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.